MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swanson, H. I.
Right arrow Articles by Yang, J.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swanson, H. I.
Right arrow Articles by Yang, J.-H.

Vol. 54, Issue 4, 671-677, October 1998

The Aryl Hydrocarbon Receptor Interacts with Transcription Factor IIB

Hollie I. Swanson and Jun-Hau Yang

Department of Pharmacology, University of Kentucky, Lexington, Kentucky 40536

The aryl hydrocarbon receptor (AHR) and its DNA binding partner, the AHR nuclear translocator (ARNT), are basic helix-loop-helix transcription factors that mediate many of the toxic and carcinogenic effects of polyhalogenated aromatic hydrocarbons. The basic regions of the AHR and ARNT contact the GCGTG recognition site, whereas both their helix-loop-helix domains and periodicity-ARNT-single-minded domains participate in heterodimerization. To delineate the transcription factors that may facilitate DNA binding and transcriptional activation of the AHR/ARNT heterodimer, we questioned whether transcription factor IIB (TFIIB) may interact with either the AHR or ARNT and whether this interaction may affect the ability of the AHR/ARNT complex to bind DNA. Coaffinity precipitation assays demonstrated that both the AHR and ARNT were capable of interacting with TFIIB. Domain mapping experiments revealed that TFIIB interacts with the periodicity-ARNT-single-minded and carboxyl-terminal regions of the AHR. To determine whether the interaction between TFIIB and the AHR may affect DNA binding of the AHR and ARNT complex, we performed gel shift experiments in the absence and presence of TFIIB. The addition of TFIIB significantly increased the formation of the AHR/ARNT DNA binding complex, but only if TFIIB was first allowed to interact with the AHR before the addition of ARNT. These results indicate that TFIIB interacts with the AHR and may stabilize the DNA binding form of the AHR and thereby augment the ability of the AHR/ARNT complex to interact with its DNA recognition site.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Tian, S. Ke, M. Chen, and T. Sheng
Interactions between the Aryl Hydrocarbon Receptor and P-TEFb: SEQUENTIAL RECRUITMENT OF TRANSCRIPTION FACTORS AND DIFFERENTIAL PHOSPHORYLATION OF C-TERMINAL DOMAIN OF RNA POLYMERASE II AT cyp1a1 PROMOTER
J. Biol. Chem., November 7, 2003; 278(45): 44041 - 44048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Kumar, P. Ramadoss, R. K. Reen, J. P. Vanden Heuvel, and G. H. Perdew
The Q-rich Subdomain of the Human Ah Receptor Transactivation Domain Is Required for Dioxin-mediated Transcriptional Activity
J. Biol. Chem., November 2, 2001; 276(45): 42302 - 42310.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson
Mechanisms of Estrogen Action
Physiol Rev, October 1, 2001; 81(4): 1535 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. J. Elferink, N.-L. Ge, and A. Levine
Maximal Aryl Hydrocarbon Receptor Activity Depends on an Interaction with the Retinoblastoma Protein
Mol. Pharmacol., April 1, 2001; 59(4): 664 - 673.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. W. Sulentic, M. P. Holsapple, and N. E. Kaminski
Putative Link between Transcriptional Regulation of IgM Expression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and the Aryl Hydrocarbon Receptor/Dioxin-Responsive Enhancer Signaling Pathway
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 705 - 716.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
D. L. Buchanan, T. Sato, R. E. Peterson, and P. S. Cooke
Antiestrogenic Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Mouse Uterus: Critical Role of the Aryl Hydrocarbon Receptor in Stromal Tissue
Toxicol. Sci., October 1, 2000; 57(2): 302 - 311.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. I. Karchner, W. H. Powell, and M. E. Hahn
Identification and Functional Characterization of Two Highly Divergent Aryl Hydrocarbon Receptors (AHR1 and AHR2) in the Teleost Fundulus heteroclitus. EVIDENCE FOR A NOVEL SUBFAMILY OF LIGAND-BINDING BASIC HELIX LOOP HELIX-PER-ARNT-SIM (bHLH-PAS) FACTORS
J. Biol. Chem., November 19, 1999; 274(47): 33814 - 33824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Kumar, R. W. Tarpey, and G. H. Perdew
Differential Recruitment of Coactivator RIP140 by Ah and Estrogen Receptors. ABSENCE OF A ROLE FOR LXXLL MOTIFS
J. Biol. Chem., August 6, 1999; 274(32): 22155 - 22164.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Huffman, A. Mokashi, H. P. Bachinger, and R. G. Brennan
The Basic Helix-Loop-Helix Domain of the Aryl Hydrocarbon Receptor Nuclear Transporter (ARNT) Can Oligomerize and Bind E-box DNA Specifically
J. Biol. Chem., October 26, 2001; 276(44): 40537 - 40544.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics